AUTHORS
Trent Hall, PhD, Rashid Mehmood, PhD2, Anitria Cotton, BS, MBA3, Austin Boucher, PhD4, Shondra M. Pruett-Miller, PhD5, John Crispino, PhD6
AFFILIATIONS
1 St. Jude Children's Research Hospital, Memphis, Tennessee, United States
2 St. Jude Children's Research Hospital, Memphis, Tennessee, United States
3 St. Jude Children's Research Hospital, Memphis, Tennessee, United States
4 St. Jude Children's Research Hospital, Memphis, Tennessee, United States
5 St. Jude Children's Research Hospital, Memphis, Tennessee, United States
6 St. Jude Children's Research Hospital, Memphis, Tennessee, United States
ABSTRACT
GATA2 deficiency is a rare autosomal dominant germline disorder characterized by immune dysfunction, bone marrow failure, and leukemic transformation early in life. In addition to myeloid disease risk, affected individuals can develop cellular deficiencies, recurrent infections, and pulmonary disease associated with dysregulation of tissue-resident lung cells such as monocytes and alveolar macrophages. Although GATA2 has been extensively studied in hematopoiesis and hematopoietic stem cell (HSC) biology using knockout models, the effects of specific high-risk GATA2 deficiency mutations remain incompletely understood.
We recently developed a murine model of the recurrent heterozygous GATA2 missense mutation, R396Q/+. R396Q/+ mice exhibit defects in definitive hematopoiesis, including impaired HSC generation through endothelial-to-hematopoietic transition (EHT), altered fetal liver hematopoietic stem and progenitor cell function, and loss of HSC stemness in adult bone marrow (BM). Because erythromyeloid progenitors (EMPs) are also generated through EHT in the yolk sac (YS), we hypothesized that EMP production would be disrupted. Flow cytometric analysis of E10 YS revealed a significant 2-fold reduction in Lineage⁻c-Kit⁺CD41⁺ EMPs in R396Q/+ embryos compared with WT littermates (P = 0.004). We further evaluated EMP-A (Lineage-c-Kit+CD41+CD34+CD93+), EMP-B (Lineage-c-Kit+CD41+CD34+CD93-), EMP-C (Lineage-c-Kit+CD41+CD34-CD93-CD45+CD16/32hi), and EMP-D (Lineage-c-Kit+CD41+CD34+-CD93-CD45-CD16/32lo) subsets. Although the frequency of each subset was reduced in R396Q/+ YS, their relative distribution within the EMP compartment was unchanged. Because EMP-A cells are thought to be multipotent precursors to downstream EMP populations, these findings suggested impaired EMP-A generation rather than altered differentiation. To directly assess EMP-A function, we performed single-cell colony-forming unit (CFU) assays on sorted E10 YS EMP-A cells. R396Q/+ EMP-A cells displayed a significant 1.5-fold reduction in CFU potential compared with WT controls (P < 0.0001). Multipotent, erythroid/megakaryocytic, and myeloid colonies were all reduced, with macrophage-rich myeloid colonies showing the largest decrease (~2.5-fold, P < 0.0001). These results demonstrate that the R396Q mutation impairs both the production and function of YS-derived EMPs.
To identify underlying mechanisms, we performed single-cell RNA sequencing (scRNA-Seq) of sorted Lineage⁻c-Kit⁺CD41⁺ EMPs from E10 WT and R396Q/+ YS using the 10X 3′ OCM platform. Based on lineage marker expression, cells were classified as multipotent (EMP-A/B; Cd93, Cd34, Ptprc high), myeloid-biased (Irf8, Csf1r high), or erythroid/megakaryocyte-biased (EMP-C/D; Gata1, Klf1, Thbs1 high). Whereas erythroid/megakaryocyte-biased clusters were unchanged, EMP-B/myeloid-biased clusters were significantly reduced in R396Q/+ samples (P = 0.0167), consistent with CFU findings. Notably, R396Q/+ EMPs contained a unique Gata2HI cluster positioned near EMP-A cells in UMAP space. GSEA demonstrated significant enrichment for GATA2 target genes in this population. Given that R396Q is predicted to reduce GATA2 DNA binding, these findings suggest compensatory upregulation of WT Gata2 expression in a subset of EMP-A cells. This Gata2HI population also exhibited reduced Cd93 and Cd34 expression, consistent with a more committed progenitor state. Together, these data support a compensatory WT Gata2 response that alters EMP-A fate and reduces downstream myeloid-biased progenitor output.
Because EMPs are a major source of tissue-resident macrophages (TRMs), including alveolar macrophages (AM), microglia, and Langerhans cells, we investigated whether embryonic EMP defects may affect adult TRM populations. Given the high prevalence of pulmonary disease in GATA2 deficiency, we analyzed lung immune populations in adult R396Q/+ mice by flow cytometry. Although alveolar macrophage numbers were unchanged, R396Q/+ lungs exhibited a significant reduction in tissue-resident monocytes accompanied by an increase in inflammatory monocytes, suggesting enhanced recruitment of BM-derived monocytes to the lung to supplement AM production. Consistent with this, scRNA-seq revealed an expansion of monocyte progenitors in R396Q/+ bone marrow.
Together, our data demonstrate that the R396Q mutation impairs YS EMP production and function, alters EMP differentiation trajectories, and may have lasting effects on tissue resident immune populations.
DISCLOSURES
Trent Hall, PhD: No relevant conflicts of interest to declare.